This US study estimated the effectiveness of nirsevimab against respiratory syncytial virus with lower respiratory tract disease in healthy term infants during the 2023-2024 season.
Your search for 2024 produced 447 results
447 results
2024
Currently loaded videos are 1 through 15 of 447 total videos.